# Personalized Therapeutic Neuromodulation for Anhedonic Depression

> **NCT05144789** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 79 (actual)

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **DEVICE:** Active TBS-DLPFC
- **DEVICE:** Active TBS-DMPFC
- **DEVICE:** Sham TBS-DLPFC or DMPFC

## Key facts

- **NCT ID:** NCT05144789
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-31
- **Primary completion:** 2025-06-06
- **Final completion:** 2025-12-31
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05144789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05144789, "Personalized Therapeutic Neuromodulation for Anhedonic Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05144789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*